Share This Article
Research Frontiers of Medicinal Plants |
DOWNLOAD |
Downloads Pharmacological Review of Ginsenoside Dammarane Saponin Rh2 Downloads Pharmacological Review of Ginsenoside Dammarane Saponin Rg1 Downloads Pharmacological Review of Ginsenoside Dammarane Saponin Rb1 Downloads Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxatriol (PPT) Downloads Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxadiol (PPD) |
Rh2 induces β-cell regeneration and lowers blood glucose level
The present study was designed to determine the antihyperglycemic function of ginsenoside Rh2 by the regeneration of β-cells in mice that underwent 70% partial pancreatectomy (PPx), and to explore the mechanisms of Rh2-induced β-cell proliferation. Adult C57BL/6J mice were subjected to PPx or a sham operation. Within 14 days post-PPx, mice that underwent PPx received Rh2 (1 mg/kg body weight) or saline injection. GS-Rh2-treated mice exhibited an improved glycemia and glucose tolerance, an increased serum insulin levels, and β-cell hyperplasia. Meanwhile, increased β-cell proliferation percentages and decreased β-cell apoptosis percentages were also observed in Rh2-treated mice. Further studies on the Akt/Foxo1/PDX-1 signaling pathway revealed that Rh2 probably induced β-cell proliferation via activation of Akt and PDX-1 and inactivation of Foxo1. Studies on the abundance and activity of cell cycle proteins suggested that GS-Rh2-induced β-cell proliferation may ultimately be achieved through the regulation of cell cycle proteins. These findings demonstrate that Rh2 administration could inhibit the tendency of apoptosis, and reverse the impaired β-cell growth potential by modulating Akt/Foxo1/PDX-1 signaling pathway and regulating cell cycle proteins. Induction of islet β-cell proliferation by Rh2 suggests its therapeutic potential in the treatment of diabetes. Source: Wang Y, Wang H, Liu Y, Li C, Qi P, Bao J. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40 |